30 min) in a dose-dependent manner prevents an increase in the ROS accumulation induced by ouabain in cerebellar granule cells [1]
Ilahi S, Beriwal N, Ilahi TB (2023) Physiology, Pineal Gland
Ozbey-Yucel U, Ucar A, Aydogan Z, Tokgoz-Yilmaz S, Beton S
Nat Med 28(10):20832091
These peptides were designed to mimic the action of these hormones (what in pharmacology is called an agonist effect) on the control of glycemia
Biosimilar developers who want to understand the patent landscape they are navigating must use sources beyond the Purple Book: litigation dockets when suits have been filed, BPPT disclosures when available, USPTO family analysis, and industry intelligence from platforms that aggregate biologic patent data across multiple primary sources